You Are Here    Home   News

PrEP will need high adherence, high effectiveness and high coverage in specific populations to be affordable in the US, New York study finds
by Gus Cairns, 2014-10-01 11:10
A study based on New York City that modelled pre-exposure prophylaxis (PrEP) uptake there has found that in order to be affordable, PrEP would need to be tightly targeted at gay men at higher risk of HIV infection. Within this target population, it would need high levels of usage. A reduction in the price of Truvada

Approximately 4.2 million over 50s are now living with HIV
by Michael Carter, 2014-09-30 09:20
Persuasive new data showing the ageing of the global HIV epidemic has been published in the online edition of AIDS. Using UNAIDS prevalence figures, investigators estimated that 4.2 million people aged 50 years or older were living with HIV in 2013. Prevalence among older people has more than doubled since 1995. Comparison with alternative data

Nearly half of HIV-positive gay men could benefit from being vaccinated against HPV, say Irish researchers
by Gus Cairns, 2014-09-29 11:10
A study of gay men in Ireland that has investigated the prevalence of infection with the human papilloma virus (HPV), some types of which cause genital warts and cervical, anal and oral cancers, concludes that 47% of HIV positive and 77% of HIV negative gay men would benefit from being given one of

Treatment of worm infections leads to increases in CD4 counts and haemoglobin and fall in viral load for HIV-positive women taking ART
by Michael Carter, 2014-09-26 09:30
De-worming is associated with falls in viral load and increases in CD4 count and haemoglobin, in pregnant women living with HIV and receiving antiretroviral therapy (ART), according to the results of a study conducted in Rwanda and published in the online edition of Clinical Infectious Diseases. Albendazole – a cheap treatment for helminth infections –